Lisa Capparelli
Head of Investor Relations
Replay available
Arbutus Biopharma Corporation (ABUS) Q3 2023 Earnings Call
Arbutus Biopharma Corporation (NASDAQ: ABUS) Q3 2023 earnings conference call, held 2023-11-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bill Collier
President and Chief Executive Officer
David Hastings
Chief Financial Officer
Michael McAhal
Chief Operating Officer
Dr Mike Sophia
Chief Scientific Officer
Dr Karen Sims
Chief Medical Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Arbutus Biopharma Corporation.
Replay transcript excerpt
WEBVTT 00:00:01.955 -- 00:00:06.679 Good day, and thank you for standing by. Welcome to the Arbutus Third Quarter Corporate 00:00:06.679 -- 00:00:11.604 and Financial Update Conference Call. At this time, all participants are in a listen-only 00:00:11.604 -- 00:00:16.248 mode. After the speaker's presentation, there will be a question and answer session. 00:00:16.248 -- 00:00:20.852 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:20.852 -- 00:00:24.715 You will then hear an automated message advising your hand is raised. 00:00:24.715 -- 00:00:28.799 To withdraw your question, please press star 1-1 again. 00:00:28.799 -- 00:00:31.942 Please be advised that today's conference is being recorded. 00:00:31.942 -- 00:00:35.407 I would now like to hand the conference over to Lisa Capparelli. 00:00:35.407 -- 00:00:37.030 Please go ahead. 00:00:37.030 -- 00:00:41.857 Thank you, Brianna. Good morning, everyone, and thank you for joining Arbutus' third 00:00:41.857 -- 00:00:45.943 quarter 2023 financial results and corporate update call. 00:00:45.943 -- 00:00:51.111 Joining me today from the Arbutus executive team are Bill Collier, President 00:00:51.111 -- 00:00:56.679 and Chief Executive Officer, David Hastings, Chief Financial Officer, 00:00:56.679 -- 00:01:00.598 Michael McAhal, Chief Operating Officer, Dr. 00:01:00.598 -- 00:01:04.302 Mike Sophia, Chief Scientific Officer, and Dr. 00:01:04.302 -- 00:01:09.448 Karen Sims, Chief Medical Officer. Bill will begin with a corporate update, 00:01:09.448 -- 00:01:14.374 followed by Dave Hastings, who will provide a review of the company's third quarter 2023 00:01:14.374 -- 00:01:20.240 financial results. After our prepared remarks, we will open the call for Q&A. 00:01:20.240 -- 00:01:...